{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:13:16Z","timestamp":1788509596249,"version":"build-2803163510"},"reference-count":36,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec id=\"st1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Spinal cord injury (SCI) produces serious neurological and medical problems. Resveratrol (RES), a natural polyphenol, possesses anti-inflammatory and antioxidant characteristics and has revealed neuroprotective ability in central nervous system diseases. This study investigated the therapeutic potential of RES in rat, mouse, and rabbit SCI models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Articles were identified from Medline, Embase, Scopus, and Web of Science until April 25, 2025. Studies evaluating RES with SCI models were included. Main results were locomotor function, inflammation, oxidative stress, apoptosis, and neuronal survival. Random-effects meta-analysis showed standardized mean differences (SMDs) and their\n                      <jats:italic>p<\/jats:italic>\n                      -values. SYRCLE\u2019s risk of bias tool and I\n                      <jats:sup>2<\/jats:sup>\n                      statistic were used for study quality and heterogeneity, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty-six studies were included. RES improved locomotor function (SMD = 3.41,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001). RES was associated with anti-inflammatory signaling, including decreased tumor necrosis factor-alpha (SMD = \u22124.64,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001), interleukin (IL)-6 (SMD = \u22123.19,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001), and IL-1\u03b2 (SMD = \u22124.10,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001). RES was associated with antioxidant signaling, including increased superoxide dismutase (SMD = 4.74,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001) and glutathione (SMD = 3.21,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001) and decreased malondialdehyde (SMD = \u22122.41,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001). RES had significant effects on apoptotic signaling, including increased B-cell Lymphoma 2 (Bcl-2) (SMD = 3.55,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001) and decreased Bcl-2-associated X protein (Bax) (SMD = \u22123.71,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.010), Bax\/Bcl-2 ratio (SMD = \u22126.83,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001), and cleaved caspase-3 (SMD = \u22124.39,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001), and terminal deoxynucleotidyl transferase dUTP nick end labeling (SMD = \u22123.81,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001). RES treatment was associated with improved neuronal survival markers, including Nissl (SMD = 3.39,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001), neuronal nuclei (SMD = 2.00,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001), and growth-associated protein 43 (SMD = 3.13,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st4\">\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In preclinical SCI models, RES is a promising neuroprotective agent. This suggests that further research is warranted regarding the potential role of RES in SCI treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/sni_815_2026","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:28:17Z","timestamp":1788506897000},"page":"498","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the neurological function and anti-inflammatory effects of resveratrol in small mammal spinal cord injury models: A systematic review and meta-analysis"],"prefix":"10.25259","volume":"17","author":[{"given":"Amirreza","family":"Peyrovinasab","sequence":"first","affiliation":[{"name":"Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pharmacoeconomics and Pharmaceutical Management, TeMS.C., Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahrokh","family":"Janmohamadi","sequence":"additional","affiliation":[{"name":"Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadhossein","family":"Vazirizadeh-Mahabadi","sequence":"additional","affiliation":[{"name":"Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Yarahmadi","sequence":"additional","affiliation":[{"name":"Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Sarveazad","sequence":"additional","affiliation":[{"name":"Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran"},{"name":"Nursing Care Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Vaccaro","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Neurosurgery, Rothman Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vafa","family":"Rahimi-Movaghar","sequence":"additional","affiliation":[{"name":"Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Yousefifard","sequence":"additional","affiliation":[{"name":"Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"10.25259\/SNI_815_2026\/ref-1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1745-7254.2006.00416.x","article-title":"Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury","volume":"27","author":"Ates","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.25259\/SNI_815_2026\/ref-2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jrsm.1414","article-title":"Funnel plots may show asymmetry in the absence of publication bias with continuous outcomes dependent on baseline risk: Presentation of a new publication bias test","volume":"11","author":"Doleman","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.25259\/SNI_815_2026\/ref-3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.expneurol.2007.06.009","article-title":"Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury","volume":"209","author":"Donnelly","year":"2008","journal-title":"Exp Neurol"},{"key":"10.25259\/SNI_815_2026\/ref-4","doi-asserted-by":"crossref","first-page":"135262","DOI":"10.1016\/j.neulet.2020.135262","article-title":"Resveratrol-primed exosomes strongly promote the recovery of motor function in SCI rats by activating autophagy and inhibiting apoptosis via the PI3K signaling pathway","volume":"736","author":"Fan","year":"2020","journal-title":"Neurosci Lett"},{"key":"10.25259\/SNI_815_2026\/ref-5","doi-asserted-by":"crossref","first-page":"1116679","DOI":"10.3389\/fnmol.2023.1116679","article-title":"Resveratrol suppresses neuroinflammation to alleviate mechanical allodynia by inhibiting Janus kinase 2\/signal transducer and activator of transcription 3 signaling pathway in a rat model of spinal cord injury","volume":"16","author":"Han","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"10.25259\/SNI_815_2026\/ref-6","doi-asserted-by":"crossref","first-page":"106377","DOI":"10.1016\/j.phrs.2022.106377","article-title":"Resveratrol suppresses microglial activation and promotes functional recovery of traumatic spinal cord via improving intestinal microbiota","volume":"183","author":"He","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.25259\/SNI_815_2026\/ref-7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.25259\/SNI_815_2026\/ref-8","first-page":"4607","article-title":"Resveratrol improves neuron protection and functional recovery through enhancement of autophagy after spinal cord injury in mice","volume":"9","author":"Hu","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.25259\/SNI_815_2026\/ref-9","first-page":"e2","article-title":"Stem cell-derived exosomes as a therapeutic option for spinal cord injuries; a systematic review and meta-analysis","volume":"13","author":"Jabermoradi","year":"2025","journal-title":"Arch Acad Emerg Med"},{"key":"10.25259\/SNI_815_2026\/ref-10","first-page":"850","article-title":"Esveratrol inhibits NLRP3 inflammasome activation in rabbits with spinal cord injury","volume":"25","author":"Jiang","year":"2020","journal-title":"Chinese J Clin Pharmacol Ther"},{"key":"10.25259\/SNI_815_2026\/ref-11","doi-asserted-by":"crossref","first-page":"100177","DOI":"10.1016\/j.mtbio.2021.100177","article-title":"Functional resveratrol-biodegradable manganese doped silica nanoparticles for the spinal cord injury treatment","volume":"13","author":"Jiang","year":"2022","journal-title":"Mater Today Bio"},{"key":"10.25259\/SNI_815_2026\/ref-12","doi-asserted-by":"crossref","first-page":"19723","DOI":"10.1038\/s41598-023-46541-x","article-title":"Resveratrol improves the prognosis of rats after spinal cord injury by inhibiting mitogen-activated protein kinases signaling pathway","volume":"13","author":"Kan","year":"2023","journal-title":"Sci Rep"},{"key":"10.25259\/SNI_815_2026\/ref-13","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1080\/10717544.2022.2104957","article-title":"Chitosan-modified hollow manganese dioxide nanoparticles loaded with resveratrol for the treatment of spinal cord injury","volume":"29","author":"Li","year":"2022","journal-title":"Drug Deliv"},{"key":"10.25259\/SNI_815_2026\/ref-14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainres.2010.11.061","article-title":"Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury","volume":"1374","author":"Liu","year":"2011","journal-title":"Brain Res"},{"key":"10.25259\/SNI_815_2026\/ref-15","first-page":"130","article-title":"Effects of resveratrol on the expression of Bcl-2 and Bax in rats with early spinal cord injury","volume":"9","author":"Liu","year":"2005","journal-title":"Chinese J Clin Rehabil"},{"key":"10.25259\/SNI_815_2026\/ref-16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jemt.23171","article-title":"Resveratrol treatment of spinal cord injury in rat model","volume":"82","author":"Liu","year":"2019","journal-title":"Microsc Res Tech"},{"key":"10.25259\/SNI_815_2026\/ref-17","first-page":"832","article-title":"Inhibition effect of resveratrol on the myelonic neuronal apoptosis in rats with spinal cord injury","volume":"34","author":"Mei","year":"2013","journal-title":"Med J Wuhan Univ"},{"key":"10.25259\/SNI_815_2026\/ref-18","first-page":"2237","article-title":"Resveratrol improves neurological outcome and neuroinflammation following spinal cord injury through enhancing autophagy involving the AMPK\/mTOR pathway","volume":"18","author":"Meng","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.25259\/SNI_815_2026\/ref-19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1124\/mol.106.022392","article-title":"Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells","volume":"70","author":"Moon","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.25259\/SNI_815_2026\/ref-20","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/jemt.24335","article-title":"Resveratrol inhibits ferroptosis via activating NRF2\/GPX4 pathway in mice with spinal cord injury","volume":"86","author":"Ni","year":"2023","journal-title":"Microsc Res Tech"},{"key":"10.25259\/SNI_815_2026\/ref-21","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.injury.2018.03.021","article-title":"Epidermal growth factor regulates apoptosis and oxidative stress in a rat model of spinal cord injury","volume":"49","author":"Ozturk","year":"2018","journal-title":"Injury"},{"key":"10.25259\/SNI_815_2026\/ref-22","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.25259\/SNI_815_2026\/ref-23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jclinepi.2019.12.021","article-title":"GRADE guidelines: 21 Part 2. Test accuracy: Inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables","volume":"122","author":"Sch\u00fcnemann","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.25259\/SNI_815_2026\/ref-24","first-page":"889","article-title":"Effects of resveratrol on inflammation and apoptosis after experimental spinal cord injury","volume":"28","author":"Senturk","year":"2018","journal-title":"Turk Neurosurg"},{"key":"10.25259\/SNI_815_2026\/ref-25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.redox.2015.12.011","article-title":"Cellular and subcellular oxidative stress parameters following severe spinal cord injury","volume":"8","author":"Visavadiya","year":"2016","journal-title":"Redox Biol"},{"key":"10.25259\/SNI_815_2026\/ref-26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bph.12301","article-title":"Treatment with resveratrol attenuates sublesional bone loss in spinal cord-injured rats","volume":"170","author":"Wang","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.25259\/SNI_815_2026\/ref-27","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.18632\/oncotarget.23877","article-title":"Resveratrol ameliorates autophagic flux to promote functional recovery in rats after spinal cord injury","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"key":"10.25259\/SNI_815_2026\/ref-28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jddst.2018.10.016","article-title":"Surface engineering of resveratrol to improve neuro-protection and functional recovery after spinal cord injury in rat","volume":"49","author":"Wang","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.25259\/SNI_815_2026\/ref-29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/jebm.12198","article-title":"The use of GRADE approach in systematic reviews of animal studies","volume":"9","author":"Wei","year":"2016","journal-title":"J Evid Based Med"},{"key":"10.25259\/SNI_815_2026\/ref-30","first-page":"1673","article-title":"Resveratrol regulates cellular activity through the PI3K\/AKT signaling pathway involved in spinal cord injury","volume":"38","author":"Xiang","year":"2024","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.25259\/SNI_815_2026\/ref-31","doi-asserted-by":"crossref","first-page":"23603","DOI":"10.18632\/aging.203628","article-title":"Resveratrol promotes axonal regeneration after spinal cord injury through activating Wnt\/\u03b2-catenin signaling pathway","volume":"13","author":"Xiang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.25259\/SNI_815_2026\/ref-32","first-page":"703","article-title":"Effects of resveratrol on secondary damages after acute spinal cord injury in rats","volume":"24","author":"Yang","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"10.25259\/SNI_815_2026\/ref-33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12896-019-0502-1","article-title":"Resveratrol alleviates lipopolysaccharide-induced inflammation in PC-12 cells and in rat model","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Biotechnol"},{"key":"10.25259\/SNI_815_2026\/ref-34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2017.02.027","article-title":"Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1\/AMPK signaling pathway","volume":"348","author":"Zhao","year":"2017","journal-title":"Neuroscience"},{"key":"10.25259\/SNI_815_2026\/ref-35","doi-asserted-by":"crossref","first-page":"136151","DOI":"10.1016\/j.neulet.2021.136151","article-title":"Resveratrol inhibits inflammation after spinal cord injury via SIRT-1\/NF-\u03baB signaling pathway","volume":"762","author":"Zhao","year":"2021","journal-title":"Neurosci Lett"},{"key":"10.25259\/SNI_815_2026\/ref-36","doi-asserted-by":"crossref","first-page":"109906","DOI":"10.1016\/j.neuropharm.2024.109906","article-title":"Resveratrol evokes neuroprotective effects and improves foot stance following kainate-induced excitotoxic damage to the mouse spinal cord","volume":"250","author":"Zylberberg","year":"2024","journal-title":"Neuropharmacology"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/investigating-the-neurological-function-and-anti-inflammatory-effects-of-resveratrol-in-small-mammal-spinal-cord-injury-models-a-systematic-review-and-meta-analysis\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/investigating-the-neurological-function-and-anti-inflammatory-effects-of-resveratrol-in-small-mammal-spinal-cord-injury-models-a-systematic-review-and-meta-analysis\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:28:22Z","timestamp":1788506902000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/investigating-the-neurological-function-and-anti-inflammatory-effects-of-resveratrol-in-small-mammal-spinal-cord-injury-models-a-systematic-review-and-meta-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":36,"alternative-id":["10.25259\/SNI_815_2026"],"URL":"https:\/\/doi.org\/10.25259\/sni_815_2026","relation":{},"ISSN":["2152-7806","2229-5097"],"issn-type":[{"value":"2152-7806","type":"electronic"},{"value":"2229-5097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"498"}}